Moriyama S, Swanson P, Nishii M, Takahashi A, Kawauchi H, Dickhoff W W, Plisetskaya E M
School of Fisheries HF-15, University of Washington, Seattle 98195.
Gen Comp Endocrinol. 1994 Oct;96(1):149-61. doi: 10.1006/gcen.1994.1167.
A specific homologous radioimmunoassay (RIA) for measurement of insulin-like growth factor-I (IGF-I) in plasma of salmonid and a few non-salmonid fish species was developed using recombinant coho salmon IGF-I (rsIGF-I) as tracer and standard, and antiserum against this peptide raised in rabbits. The minimum detection level of IGF-I was 1.5 ng/ml and linearity was obtained in a range from 1.5 to 23 ng/ml. No cross-reaction was detected in the salmon IGF-I RIA with mammalian growth factors, salmon pituitary hormones, salmon or mammalian insulin, or any peptide in rat plasma. Although salmon IGF-I has high sequence similarity to mammalian IGF-I, it did not cross-react with anti-human IGF-I serum in human RIA and serial dilutions of plasma from salmon were not parallel to the human IGF-I standards in this assay system. In contrast, dilution curves for plasma of salmonids, such as coho (Oncorhynchus kisutch), Atlantic (Salmo salar), and sockeye (O. nerka) salmon, rainbow trout (O. mykiss), some other teleost fish, such as tilapia (Oreochromis mossabmica), carp (Cyprus carpio), eel (Anguilla rostrata), Atlantic halibut (Hippoglossus hippoglossus), and agnathan, the sea lamprey (Petromyzon marinus), assessed in salmon IGF-I RIA were parallel to the rsIGF-I standards. Acid-ethanol extraction of plasma samples altered the molecular weight, but not the quantity, of immunoreactive IGF-I, implying that IGF-I binding proteins in salmon plasma do not affect the performance of the salmon IGF-I RIA. Gel filtration of nonacidified plasma on a Sephadex G-75 superfine column produced two immunoreactive IGF-I peaks of molecular weights of approximately > 70 k and 7 kDa, whereas acidification of plasma increased the relative amount of the 7-kDa peak (IGF-I) and the > 70-kDa peak disappeared. The recoveries of rsIGF-I added to extracted or nonextracted plasma were 97.4 and 94.9%, respectively. Inter- and intraassay coefficients of variation were 3.6 and 3.3%, respectively. Plasma IGF-I levels in coho salmon smolts were 117.4 +/- 19.1 ng/ml as compared to IGF-I levels in parr (45.3 +/- 2.5 ng/ml) or in adult fish (45.2 +/- 5.4 ng/ml) measured in the same assay. Injection of salmon growth hormone, but not prolactin or somatolactin, caused a significant and dose-dependent elevation of plasma IGF-I levels, while either fasting or injection of streptozotocin led to a significant decline in systemic IGF-I.(ABSTRACT TRUNCATED AT 400 WORDS)
利用重组银大麻哈鱼胰岛素样生长因子-I(rsIGF-I)作为示踪剂和标准品,以及用该肽在兔体内产生的抗血清,开发了一种用于测定鲑科鱼类及少数非鲑科鱼类血浆中胰岛素样生长因子-I(IGF-I)的特异性同源放射免疫分析(RIA)方法。IGF-I的最低检测水平为1.5 ng/ml,在1.5至23 ng/ml范围内呈线性。在鲑鱼IGF-I RIA中,未检测到与哺乳动物生长因子、鲑鱼垂体激素、鲑鱼或哺乳动物胰岛素,或大鼠血浆中的任何肽发生交叉反应。尽管鲑鱼IGF-I与哺乳动物IGF-I具有高度的序列相似性,但在人RIA中它与抗人IGF-I血清不发生交叉反应,并且在该检测系统中,鲑鱼血浆的系列稀释液与人类IGF-I标准品不平行。相反,在鲑鱼IGF-I RIA中评估的鲑科鱼类血浆的稀释曲线,如银大麻哈鱼(Oncorhynchus kisutch)、大西洋鲑(Salmo salar)和红大麻哈鱼(O. nerka)、虹鳟(O. mykiss),以及其他一些硬骨鱼,如罗非鱼(Oreochromis mossabmica)、鲤鱼(Cyprus carpio)、鳗鱼(Anguilla rostrata)、大西洋大比目鱼(Hippoglossus hippoglossus),和无颌类的海七鳃鳗(Petromyzon marinus),与rsIGF-I标准品平行。血浆样品的酸乙醇提取改变了免疫反应性IGF-I的分子量,但不影响其数量,这意味着鲑鱼血浆中的IGF-I结合蛋白不影响鲑鱼IGF-I RIA的性能。在Sephadex G-75超细柱上对未酸化血浆进行凝胶过滤产生了两个免疫反应性IGF-I峰,分子量分别约>70 kDa和7 kDa,而血浆酸化增加了7 kDa峰(IGF-I)的相对量,>70 kDa峰消失。添加到提取或未提取血浆中的rsIGF-I的回收率分别为97.4%和94.9%。批间和批内变异系数分别为3.6%和3.3%。在同一检测中,银大麻哈鱼幼鲑的血浆IGF-I水平为117.4±19.1 ng/ml,而幼鱼(45.3±2.5 ng/ml)或成鱼(45.2±5.4 ng/ml)中的IGF-I水平则较低。注射鲑鱼生长激素,但不是催乳素或生长抑素,导致血浆IGF-I水平显著且呈剂量依赖性升高,而禁食或注射链脲佐菌素则导致全身IGF-I显著下降。(摘要截短于400字)